Stockyoda,Possible.. but maybe just Soverign risk ON/off, with Mali sanctions and Congo ML uncertainty.Back to Core, AGM about 7 weeks ago stated LiOH scoping study by H2 2022. So say report lands on desk Xmas, some light reading over Xmas/new year, early January prepare Board papers. Previous announcements 'Board approved' mid month, so say January Board meeting nowish, then maybe Big announcement very soon, say next week.By big announcement my thinking, LiOH is a go, good feedstock from 4000 assay results, fully funded from Stage 1 profits.. still early days need PFS, DFS, FID, etc, but good news. Could fund managers also be sensing?
Stockyoda,Possible.. but maybe just Soverign risk ON/off, with...
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.3¢ |
Change
-0.003(1.61%) |
Mkt cap ! $325.8M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.8¢ | 15.0¢ | $636.1K | 4.119M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 131 | 5335996 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 1629402 | 105 |
View Market Depth
| Last trade - 14.38pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
15.5¢ |
Change
-0.003 ( 1.52 %) |
||||
| Open | High | Low | Volume | ||
| 15.8¢ | 15.8¢ | 15.0¢ | 2607300 | ||
| Last updated 14.57pm 21/05/2024 ? | |||||
| CXO (ASX) Chart |